Advertisement

Transapical Transcatheter Aortic Valve Replacement

Chapter

Abstract

Transcatheter aortic valve replacement has become an acceptable and increasingly common treatment for aortic stenosis. While its use was initially limited to patients deemed prohibitively high risk for surgery, indications for transcatheter therapy continue to expand. Although the transfemoral route is increasingly utilized, the transapical approach is an indispensable part of the surgeon’s armamentarium for difficult-access patients. Moreover, since future transcatheter interventions will likely utilize the transapical approach, it is incumbent on cardiac surgeons to become facile with this exposure.

Keywords

Transcatheter aortic valve replacement TAVR Transapical Aortic stenosis PARTNER trial 

References

  1. 1.
    Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: Why are so many denied surgery? Eur Heart J. 2005;26(24):2714–20. doi: 10.1093/eurheartj/ehi471.CrossRefPubMedGoogle Scholar
  2. 2.
    Bouma BJ, van Den Brink RB, van Der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999;82(2):143–8. doi: 10.1136/hrt.82.2.143.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607. doi: 10.1056/NEJMoa1008232.CrossRefPubMedGoogle Scholar
  4. 4.
    Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82(6):2111–5. doi: 10.1016/j.athoracsur.2006.07.048.CrossRefPubMedGoogle Scholar
  5. 5.
    Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98. doi: 10.1097/01.SA.0000410147.99581.d4.CrossRefPubMedGoogle Scholar
  6. 6.
    Lutter G, Quaden R, Osaki S, et al. Off-pump transapical mitral valve replacement. Eur J Cardiothorac Surg. 2009;36(1):124–8. doi: 10.1016/j.ejcts.2009.02.037.CrossRefPubMedGoogle Scholar
  7. 7.
    Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(22):e57–185. doi: 10.1016/j.jacc.2014.02.536.CrossRefPubMedGoogle Scholar
  8. 8.
    Miller DC, Blackstone EH, MacK MJ, et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143(4):832–43. doi: 10.1016/j.jtcvs.2012.01.055.CrossRefPubMedGoogle Scholar
  9. 9.
    Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack M, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MBSL. Propensity-matched comparison of clinical outcomes after transapical vs. transfemoral TAVR. Circulation. 2015;131(22):1989–2000.CrossRefPubMedGoogle Scholar
  10. 10.
    Dewey TM, Bowers B, Thourani VH, et al. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER Trial. Ann Thorac Surg. 2013;96(6):2083–9. doi: 10.1016/j.athoracsur.2013.05.093.CrossRefPubMedGoogle Scholar
  11. 11.
    Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60(15):1438–54. doi: 10.1016/j.jacc.2012.09.001.CrossRefPubMedGoogle Scholar
  12. 12.
    Thomas MS. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122(1):62–9. doi: 10.1161/CIRCULATIONAHA.109.907402.CrossRefPubMedGoogle Scholar
  13. 13.
    Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol. 2009;54(4):303–11. doi: 10.1016/j.jacc.2009.04.032.CrossRefPubMedGoogle Scholar
  14. 14.
    Rodés-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2010;57(1):18–28. doi: 10.1016/j.jacc.2010.07.036.CrossRefGoogle Scholar
  15. 15.
    Murarka S, Lazkani M, Neihaus M, Bogess M, Morris M, Gellert G, Fang HKPA. Comparison of 30-day outcomes of transfemoral versus transapical approach of transcatheter aortic valve replacement. Ann Thorac Surg. 2015;99:1539–45.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Division of Thoracic and Cardiovascular Surgery, Department of SurgeryThe University of Virginia Hospital Medical CenterCharlottesvilleUSA
  2. 2.Section of Adult Cardiac Surgery, Department of Surgery, Advanced Cardiac Valve CenterUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations